Vicente Maria-Santa

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Long-term sequelae and quality of life after childhood-onset craniopharyngioma: Results of a Spanish multicenter study.

Long-term sequelae and quality of life after childhood-onset craniopharyngioma: Results of a Spanish multicenter study.

Journal: Pediatric blood & cancer
Published: June 11, 2024

EpiGe: A machine-learning strategy for rapid classification of medulloblastoma using PCR-based methyl-genotyping.

EpiGe: A machine-learning strategy for rapid classification of medulloblastoma using PCR-based methyl-genotyping.

Journal: iScience
Published: March 31, 2023

Clinical and Molecular Evolution of an ALK-Driven Infant-Type Hemispheric Glioma Treated Sequentially With Second- and Third-Generation Anaplastic Lymphoma Kinase Inhibitors.

Clinical and Molecular Evolution of an ALK-Driven Infant-Type Hemispheric Glioma Treated Sequentially With Second- and Third-Generation Anaplastic Lymphoma Kinase Inhibitors.

Journal: JCO precision oncology
Published: March 30, 2023

Syngeneic hematopoietic stem cell transplantation after mobilization failure in an adolescent with intracranial germ cell tumor.

Syngeneic hematopoietic stem cell transplantation after mobilization failure in an adolescent with intracranial germ cell tumor.

Journal: Pediatric blood & cancer
Published: November 15, 2022

Corrigendum to "How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain": [ESMO Open, 7 (2022) 100462].

Corrigendum to "How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain": [ESMO Open, 7 (2022) 100462].

Journal: ESMO open
Published: June 01, 2022

Seizure control in tumor-associated epilepsy secondary to BRAF inhibition.

Seizure control in tumor-associated epilepsy secondary to BRAF inhibition.

Journal: Pediatric blood & cancer
Published: May 23, 2022

How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain.

How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain.

Journal: ESMO open
Published: February 18, 2022

Langerhans cell histiocytosis. Advances in pathogenesis and clinical practice.

Langerhans cell histiocytosis. Advances in pathogenesis and clinical practice.

Journal: Anales de pediatria
Published: December 31, 2021

Naxitamab combined with granulocyte-macrophage colony-stimulating factor as consolidation for high-risk neuroblastoma patients in complete remission.

Naxitamab combined with granulocyte-macrophage colony-stimulating factor as consolidation for high-risk neuroblastoma patients in complete remission.

Journal: Pediatric blood & cancer
Published: April 01, 2021

Clinical and Pathological Evidence of Anti-GD2 Immunotherapy Induced Differentiation in Relapsed/Refractory High-Risk Neuroblastoma.

Clinical and Pathological Evidence of Anti-GD2 Immunotherapy Induced Differentiation in Relapsed/Refractory High-Risk Neuroblastoma.

Journal: Cancers
Published: February 15, 2021

Prognostic value of patient-derived xenograft engraftment in pediatric sarcomas.

Prognostic value of patient-derived xenograft engraftment in pediatric sarcomas.

Journal: The journal of pathology. Clinical research
Published: December 14, 2020

Craniospinal irradiation as a salvage treatment for metastatic relapsed DIPG.

Craniospinal irradiation as a salvage treatment for metastatic relapsed DIPG.

Journal: Pediatric blood & cancer
Published: August 20, 2020
Showing 1-12 of 18

Last Updated: 09/26/2026